PACB
Pacific Biosciences of California Inc.
Company Overview
| Mkt Cap | $591.73M | Price | $2.34 |
| Volume | 22.75M | Change | +20.62% |
| P/E Ratio | -1.9 | Open | $2.07 |
| Revenue | $154.0M | Prev Close | $1.94 |
| Net Income | $-309.9M | 52W Range | $0.85 - $2.72 |
| Div Yield | N/A | Target | $2.16 |
| Overall | 57 | Value | 40 |
| Quality | -- | Technical | 75 |
No chart data available
Stock Overview
Updated DailyPacific Biosciences of California Inc. (PACB) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $2.34 with a market capitalization of $591.73 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows PACB with a volume of 22.75 million shares. The stock opened up 6.44% from yesterday's close of $1.94. Current analyst estimates project earnings of $-0.56 per share for this year, with next year targeting $-0.54.
PACB demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ILMN, NSTG, PKI, TMO, FLDM.
Key investment considerations for PACB include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -7.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 04:14 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PACB | $2.34 | +20.6% | 22.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pacific Biosciences of California Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW